Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002037806 | SCV002229113 | pathogenic | Spastic paraplegia | 2021-11-07 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. This variant has not been reported in the literature in individuals affected with SACS-related conditions. This variant is present in population databases (rs765667160, gnomAD 0.006%). This sequence change creates a premature translational stop signal (p.Thr458Alafs*21) in the SACS gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in SACS are known to be pathogenic (PMID: 18465152, 20876471). |